Clinical Trial Update: Intranasal Dexmedetomidine for Acute Anxiety State in Adults: A Randomized Trial [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating intranasal dexmedetomidine for acute anxiety in adults; the study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders

Drugs mentioned

• Dexmedetomidine (intranasal) (dexmedetomidine)

Snippet

Sponsor: Tongji University | Conditions: Acute Anxiety States | Phase 2 | Status: NOT_YET_RECRUITING